Hawkins (NASDAQ:HWKN) Earns Market Perform Rating from Analysts at Raymond James Financial

Analysts at Raymond James Financial initiated coverage on shares of Hawkins (NASDAQ:HWKN - Get Free Report) in a research note issued to investors on Thursday, MarketBeat Ratings reports. The firm set a "market perform" rating on the specialty chemicals company's stock.

Several other equities research analysts have also recently weighed in on the stock. BWS Financial reaffirmed a "buy" rating and set a $160.00 price objective on shares of Hawkins in a research report on Thursday, May 15th. CJS Securities began coverage on shares of Hawkins in a research report on Tuesday, April 1st. They set a "market outperform" rating and a $125.00 price objective for the company. Finally, Wall Street Zen downgraded Hawkins from a "buy" rating to a "hold" rating in a research note on Saturday, July 5th.

Hawkins Stock Performance

HWKN stock traded up $2.46 during midday trading on Thursday, reaching $160.85. 522,954 shares of the company were exchanged, compared to its average volume of 147,649. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.15 and a quick ratio of 1.37. The business has a 50-day moving average price of $142.84 and a two-hundred day moving average price of $123.03. Hawkins has a one year low of $98.30 and a one year high of $165.87. The firm has a market capitalization of $3.36 billion, a price-to-earnings ratio of 39.81, a price-to-earnings-growth ratio of 2.70 and a beta of 0.85.

Hawkins (NASDAQ:HWKN - Get Free Report) last announced its earnings results on Wednesday, May 14th. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.74 by $0.04. The company had revenue of $245.32 million during the quarter, compared to analysts' expectations of $230.69 million. Hawkins had a net margin of 8.66% and a return on equity of 18.93%. Equities research analysts forecast that Hawkins will post 4 EPS for the current year.

Hedge Funds Weigh In On Hawkins

A number of institutional investors and hedge funds have recently modified their holdings of the business. SkyOak Wealth LLC raised its position in Hawkins by 3.8% in the 1st quarter. SkyOak Wealth LLC now owns 2,374 shares of the specialty chemicals company's stock valued at $251,000 after buying an additional 88 shares during the last quarter. GAMMA Investing LLC raised its position in Hawkins by 20.4% in the 1st quarter. GAMMA Investing LLC now owns 531 shares of the specialty chemicals company's stock valued at $56,000 after buying an additional 90 shares during the last quarter. Summit Investment Advisors Inc. raised its position in Hawkins by 5.1% in the 4th quarter. Summit Investment Advisors Inc. now owns 2,023 shares of the specialty chemicals company's stock valued at $248,000 after buying an additional 99 shares during the last quarter. Hsbc Holdings PLC raised its position in Hawkins by 3.7% in the 1st quarter. Hsbc Holdings PLC now owns 2,976 shares of the specialty chemicals company's stock valued at $313,000 after buying an additional 105 shares during the last quarter. Finally, Focus Financial Network Inc. raised its position in Hawkins by 5.7% in the 2nd quarter. Focus Financial Network Inc. now owns 2,199 shares of the specialty chemicals company's stock valued at $312,000 after buying an additional 119 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors.

Hawkins Company Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.